Company: RPID
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0001380106-25-000089
Chunk: 36

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 36
---
 annual director fee of $40,000;

• If the director serves as lead director or chair or on a committee of our Board, an additional annual fee as follows:

◦ Chair of the Board or lead director, $45,000;

◦ Chair of the Audit Committee, $20,000;

◦ Audit Committee member other than the Chair, $10,000;

◦ Chair of the Compensation Committee, $15,000;

◦ Compensation Committee member other than the Chair, $7,500;

◦ Chair of the Nominating and Corporate Governance Committee, $10,000; and

◦ Nominating and Corporate Governance Committee member other than the Chair, $5,000.

Director fees are payable quarterly in arrears, provided that the amount of each payment will be prorated for any portion of a quarter that a director is not serving on our Board or an applicable committee.

#### Equity Compensation
• Initial Awards : Each non-employee director who is initially elected or appointed to serve on our Board will be granted, on the date on which such non-employee director is appointed or elected to serve on the board, an option to purchase 50,000 shares of our Class A common stock with an exercise price per share equal to the fair market value of a share of our Class A common stock on the date of grant. These initial options will vest in 36 equal monthly installments following the date of grant, such that the initial options will be fully vested and exercisable on the third anniversary of the date of grant, subject to the non-employee director’s continued service as a non-employee director through the applicable vesting date.

• Subsequent Awards : Each non-employee director who (i) has been serving on our Board for at least six months as of the date of any annual meeting of our stockholders and (ii) will continue to serve as a director immediately following such meeting automatically will be granted, on such annual meeting date, from March 9, 2023, through February 5, 2024, an option to purchase 25,000 shares of our Class A common stock, and from February 6, 2024, onwards, (A) an option to purchase 28,650 shares of our Class A common stock with an exercise price per share equal to the fair market value of a share of our Class A common stock on the date of grant, and (B) restricted stock units in the amount of 14,300 units on the